Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marika Nespi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
AAPS Pharmscitech|December 21, 2021
Optimization of Spray-Drying Parameters for Formulation Development at Preclinical ScaleMarika Nespi, Robert Kuhn, Chun-Wan Yen, et al.
Journal of Pharmaceutical Sciences|November 1, 2024
Vehicle effect on in-vitro and in-vivo performance of spray-dried dispersionsMarika Nespi, Justin Ly, Yuchen Fan, et al.
Nature Communications|October 30, 2020
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signalingRakshamani Tripathi, Zulong Liu, Aditi Jain, et al.
Clinical and Experimental Medicine|December 8, 2018
PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumorsYemarshet K Gebreyohannes, Elizabeth A Burton, Agnieszka Wozniak, et al.
Nature Communications|August 23, 2019
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease modelElizabeth Spangenberg, Paul L Severson, Lindsay A Hohsfield, et al.
Npj Drug Discovery|June 30, 2026
Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegenerationRebecca R Leahey, Martin Weber, Chang Hoon Cho, et al.
Journal of Neuropathology and Experimental Neurology|June 6, 2025
Compound muscle action potential as an early functional in vivo measure of Sarm1 inhibition after sciatic nerve transectionSeong Kwon Hur, Rebecca R Leahey, Mitchell Geringer, et al.
ACS Medicinal Chemistry Letters|June 18, 2025
Optimization of Brain Penetrant SARM1 Orthosteric Inhibitors and Discovery of Their Paradoxical Subinhibitory ActivationSamantha A Green, Russell T Smith, Jessica M Grandner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitorChao Zhang, Prabha N Ibrahim, Jiazhong Zhang, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)Mingshuo Zeng, Jessica M Grandner, Marian C Bryan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
AAPS Pharmscitech|December 21, 2021
Optimization of Spray-Drying Parameters for Formulation Development at Preclinical ScaleMarika Nespi, Robert Kuhn, Chun-Wan Yen, et al.
Journal of Pharmaceutical Sciences|November 1, 2024
Vehicle effect on in-vitro and in-vivo performance of spray-dried dispersionsMarika Nespi, Justin Ly, Yuchen Fan, et al.
Nature Communications|October 30, 2020
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signalingRakshamani Tripathi, Zulong Liu, Aditi Jain, et al.
Clinical and Experimental Medicine|December 8, 2018
PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumorsYemarshet K Gebreyohannes, Elizabeth A Burton, Agnieszka Wozniak, et al.
Nature Communications|August 23, 2019
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease modelElizabeth Spangenberg, Paul L Severson, Lindsay A Hohsfield, et al.
Npj Drug Discovery|June 30, 2026
Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegenerationRebecca R Leahey, Martin Weber, Chang Hoon Cho, et al.
Journal of Neuropathology and Experimental Neurology|June 6, 2025
Compound muscle action potential as an early functional in vivo measure of Sarm1 inhibition after sciatic nerve transectionSeong Kwon Hur, Rebecca R Leahey, Mitchell Geringer, et al.
ACS Medicinal Chemistry Letters|June 18, 2025
Optimization of Brain Penetrant SARM1 Orthosteric Inhibitors and Discovery of Their Paradoxical Subinhibitory ActivationSamantha A Green, Russell T Smith, Jessica M Grandner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitorChao Zhang, Prabha N Ibrahim, Jiazhong Zhang, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)Mingshuo Zeng, Jessica M Grandner, Marian C Bryan, et al.
Pageof 2